This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Manisha Koirala, Bollywood Actress, Joins The Binaytara Foundation In Nepal For The International Conference On Advances In Hematologic Malignancies

KATHMANDU, Nepal, Sept. 14, 2013 /PRNewswire/ -- The Binaytara Foundation (BTF) is holding its second Advances in Medicine conference in Nepal. The International Conference on Advances in Hematologic Malignancies, which will run from September 13th to 14th at the Regal Conference Hall, Hotel Yak and Yeti, Darbarmarg, Kathmandu, Nepal provides balanced educational sessions focusing on the needs of hematologists, oncologists and other healthcare professionals involved in the treatment of patients with blood cancer.

Famous Bollywood actress and Chief Guest, Manisha Koirala, stated today, "As I look back on my life, I have played 3 major roles. First, a daughter, second an actress... and the third, cancer crusader. I don't like being called a survivor, it is too meek. We should all be cancer crusaders." Miss Koirala, a cancer survivor herself, praised BTF's efforts to help improve cancer care in Nepal.

Over 300 delegates from 12 countries, including Nepal, Pakistan, Australia, USA, India, China, Poland, Turkey, Czechoslovakia, Sri Lanka, Bhutan, and Bangladesh attended the educational and scientific sessions today that focused on the recent developments in the diagnosis and management of various forms of cancer.

Although there is no official data on blood cancer incidences in Nepal, an estimated 800 patients with various forms of blood cancers are diagnosed in Nepal's cancer hospitals each year. The figure is estimated to be much higher in the country as many patients remain undiagnosed due to lack of access to healthcare.

BTF and the University of Illinois Hospital and Health Sciences System have partnered with the Civil Service Hospital of Kathmandu, Nepal, in a project to develop the country's first Bone Marrow Transplant (BMT) Center. A BMT facility in Kathmandu will serve thousands of patients from Nepal and neighboring states of India.

Binaytara Foundation (BTF) is an Illinois-based, 501(c)3 non-profit organization. BTF charitable projects include medical research grants and the application of telemedicine to serve patients in third world countries. For more information on BTF projects, visit

This press release was issued through For further information, visit

SOURCE The Binaytara Foundation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs